Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ibuprofen Safety Questioned For High-Risk Cardio Patients – Study

This article was originally published in The Tan Sheet

Executive Summary

Medical practitioners should use caution in prescribing ibuprofen to low-dose aspirin users who are considered high-risk for cardiac events, according to a study published in the June Annals of the Rheumatic Diseases

You may also be interested in...



Naproxen Fares Better Than Ibuprofen In Cardiovascular-Risk Data

Traditional non-selective NSAIDs, with the exception of naproxen, carry similar cardiovascular risk to COX-2 inhibitors, according to results of a study released by the Agency for Healthcare Research & Quality (AHRQ) Sept. 25

Doc of Detox Black Gold Supplement Tarnished Without Support For Claims

Doc of Detox Black Gold supplement claims for Alzheimer’s, cancer, diabetes, fatigue and heavy metal toxicity were reviewed in industry self-regulation forum. But Canadian firm International Institute of Health didn’t submit supporting evidence.

Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention

Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.

Topics

UsernamePublicRestriction

Register

PS100752

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel